Feb 27, 2012
Diabetic Gastroparesis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Feb 27, 2012
The Myelofibrosis Therapeutics Market is Forecast to Show Significant Growth until 2019
Feb 27, 2012
The Amnesia Therapeutics Market is Forecast to Show Low Growth Until 2019
Feb 24, 2012
The Graves’ Disease Therapeutics Market is Forecast to Show Very Slow Growth until 2019
Feb 24, 2012
The Sjögren’s Syndrome Therapeutics Market is Forecast to Show Steady Growth until 2019
Feb 24, 2012
Chronic Urticaria or Hives Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Feb 24, 2012
The Global Schizophrenia Therapeutics Market is Poised to Witness a Significant Decline Through 2020
Feb 15, 2012
The Unstable Angina Therapeutics Market Expected to Show Slow Growth until 2018
Feb 15, 2012
The Aplastic Anemia Market is Forecast to Show Slow Growth until 2019
Feb 15, 2012
The Global Type 2 Diabetes Therapeutics Market was worth $23.7 Billion in 2011, Driven by the Growth in the Patient Volume and Annual Cost of Type 2 Diabetes Therapy